FI905200A0 - Kondenserade imidazolderivat och foerfarande foer deras framstaellning. - Google Patents

Kondenserade imidazolderivat och foerfarande foer deras framstaellning.

Info

Publication number
FI905200A0
FI905200A0 FI905200A FI905200A FI905200A0 FI 905200 A0 FI905200 A0 FI 905200A0 FI 905200 A FI905200 A FI 905200A FI 905200 A FI905200 A FI 905200A FI 905200 A0 FI905200 A0 FI 905200A0
Authority
FI
Finland
Prior art keywords
faring
condensers
immediate
frequency
immediate condensers
Prior art date
Application number
FI905200A
Other languages
English (en)
Inventor
Teruo Oku
Hiroyuki Setoi
Hiroshi Kayakiri
Takayuki Inoue
Akio Kuroda
Akira Katayama
Masashi Hashimoto
Sigeki Satoh
Hirokazu Tanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898924458A external-priority patent/GB8924458D0/en
Priority claimed from GB898929069A external-priority patent/GB8929069D0/en
Priority claimed from GB909011336A external-priority patent/GB9011336D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI905200A0 publication Critical patent/FI905200A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI905200A 1989-10-31 1990-10-23 Kondenserade imidazolderivat och foerfarande foer deras framstaellning. FI905200A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898924458A GB8924458D0 (en) 1989-10-31 1989-10-31 Condensed imidazole derivatives and a process for preparation thereof
GB898929069A GB8929069D0 (en) 1989-12-22 1989-12-22 Condensed imidazole derivatives and process for preparation thereof
GB909011336A GB9011336D0 (en) 1990-05-21 1990-05-21 Condensed imidazole derivatives and process for preparation thereof

Publications (1)

Publication Number Publication Date
FI905200A0 true FI905200A0 (fi) 1990-10-23

Family

ID=27264770

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905200A FI905200A0 (fi) 1989-10-31 1990-10-23 Kondenserade imidazolderivat och foerfarande foer deras framstaellning.

Country Status (13)

Country Link
EP (1) EP0426021A1 (fi)
JP (2) JPH03188076A (fi)
KR (1) KR910007927A (fi)
CN (1) CN1051358A (fi)
AU (1) AU6560390A (fi)
CA (1) CA2028880A1 (fi)
FI (1) FI905200A0 (fi)
HU (1) HUT55779A (fi)
IE (1) IE903815A1 (fi)
IL (1) IL96019A0 (fi)
NO (1) NO904694L (fi)
PH (1) PH27020A (fi)
PT (1) PT95745A (fi)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332744A (en) * 1989-05-30 1994-07-26 Merck & Co., Inc. Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5223499A (en) * 1989-05-30 1993-06-29 Merck & Co., Inc. 6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
US5250554A (en) * 1989-10-24 1993-10-05 Takeda Chemical Industries, Ltd. Benzimidazole derivatives useful as angiotensin II inhibitors
IL97219A (en) * 1990-02-19 1995-12-08 Ciba Geigy Ag Elliptical amino compounds converted by biphenyl process for their preparation and pharmaceutical preparations containing them
US5194379A (en) * 1990-05-11 1993-03-16 Merck & Co., Inc. Microbial transformation process for the preparation of hydroxylanol imidazo (4,5-b) pyridines useful as angiotensin II receptor antagonists
CA2044806A1 (en) * 1990-07-18 1992-01-19 Roland Jaunin Purine derivatives
CA2047029A1 (en) * 1990-07-19 1992-01-20 Shieh-Shung T. Chen Microbial transformation process for antihypertensive products
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
DE4023369A1 (de) * 1990-07-23 1992-01-30 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0470543A1 (de) * 1990-08-10 1992-02-12 Dr. Karl Thomae GmbH Heterocyclische Imidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zur ihrer Herstellung
WO1992004343A1 (en) * 1990-09-04 1992-03-19 Yamanouchi Pharmaceutical Co., Ltd. Novel tetrahydrobenzazole derivative
US5210092A (en) * 1990-09-25 1993-05-11 Fujisawa Pharmaceutical Co., Ltd. Angiotensin ii antagonizing heterocyclic derivatives
AU9024591A (en) * 1990-10-25 1992-05-26 G.D. Searle & Co. Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders
AU657498B2 (en) * 1990-12-14 1995-03-16 Novartis Ag Biphenylyl compounds
US5614519A (en) * 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
US5594003A (en) * 1991-02-06 1997-01-14 Dr. Karl Thomae Gmbh Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5602127A (en) * 1991-02-06 1997-02-11 Karl Thomae Gmbh (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
TW274551B (fi) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
US5506361A (en) * 1991-05-08 1996-04-09 Theupjohn Company Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
JPH05112533A (ja) * 1991-05-08 1993-05-07 Upjohn Co:The イミダゾベンゾキノン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
AU1751192A (en) * 1991-05-16 1992-12-30 Glaxo Group Limited Benzofuran derivatives
ES2098403T3 (es) * 1991-09-10 1997-05-01 Tanabe Seiyaku Co Derivados de la imidazoindolizina y procedimiento para su preparacion.
WO1993019067A1 (en) * 1991-09-12 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine derivatives as angiotensin ii antagonists
GB9201789D0 (en) * 1992-01-28 1992-03-11 Fujisawa Pharmaceutical Co Heterocyclic derivatives
US5354759A (en) * 1991-09-12 1994-10-11 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic compounds
JPH06107661A (ja) * 1991-10-24 1994-04-19 Upjohn Co:The イミダゾール誘導体およびこれを有効成分とする医薬組成物
US5442062A (en) * 1991-10-24 1995-08-15 The Upjohn Company Imidazole derivatives and pharmaceutical compositions containing the same
US5283242A (en) * 1991-10-24 1994-02-01 American Home Products Corporation Substituted benzimidazoles and quinazolines as antihypertensives
TW284688B (fi) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
GB9201715D0 (en) * 1992-01-28 1992-03-11 Ici Plc Chemical process
DE4219534A1 (de) * 1992-02-19 1993-12-16 Thomae Gmbh Dr K Substituierte Biphenylylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
JPH07507271A (ja) * 1992-03-03 1995-08-10 藤沢薬品工業株式会社 アンジオテンシン１１拮抗剤としてのベンズイミダゾール誘導体
ATE171946T1 (de) * 1992-07-10 1998-10-15 Knoll Ag Dioxcyclobutenderivate als angiotensin ii antagonisten
WO1994002142A1 (en) * 1992-07-17 1994-02-03 Merck & Co., Inc. Substituted biphenylmethylimidazopyridines
GB9217820D0 (en) * 1992-08-21 1992-10-07 Fujisawa Pharmaceutical Co New use
DE69332736T2 (de) * 1992-12-07 2004-03-25 Eisai Co., Ltd. Verfahren zur herstellung von imidazopyridinderivaten und zwischenprodukte
KR0151816B1 (ko) * 1994-02-08 1998-10-15 강박광 신규의 치환된 피리딜 이미다졸 유도체 및 그의 제조방법
KR0132001B1 (ko) * 1994-05-21 1998-04-17 강박광 신규한 치환된 이미다졸 유도체
KR0151819B1 (ko) * 1994-06-11 1998-10-15 강박광 신규의 피리딜 n-옥사이드로 치환된 피디딜이미다졸 유도체 및 그의 제조방법
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US7115653B2 (en) 2000-03-30 2006-10-03 Curis, Inc. Small organic molecule regulators of cell proliferation
US6613798B1 (en) * 2000-03-30 2003-09-02 Curis, Inc. Small organic molecule regulators of cell proliferation
US8852937B2 (en) 2000-03-30 2014-10-07 Curis, Inc. Small organic molecule regulators of cell proliferation
US6683108B1 (en) * 2000-03-30 2004-01-27 Curis, Inc. Agonists of hedgehog signaling pathways and uses related thereto
US6683192B2 (en) * 2000-03-30 2004-01-27 Curis, Inc. Small organic molecule regulators of cell proliferation
US8187727B2 (en) 2005-07-22 2012-05-29 Lg Chem, Ltd. Imidazole derivatives, preparation method thereof and organic electronic device using the same
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CN104163792B (zh) * 2013-05-20 2017-04-12 湖南化工研究院 N‑吡啶酰胺类化合物及其制备方法与应用
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
EP0400835A1 (en) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituted benzimidazoles as angiotensin II antagonists

Also Published As

Publication number Publication date
IL96019A0 (en) 1991-07-18
CA2028880A1 (en) 1991-05-01
HUT55779A (en) 1991-06-28
PT95745A (pt) 1991-09-13
AU6560390A (en) 1991-05-09
HU906947D0 (en) 1991-05-28
JPH03184976A (ja) 1991-08-12
CN1051358A (zh) 1991-05-15
IE903815A1 (en) 1991-05-08
KR910007927A (ko) 1991-05-30
NO904694D0 (no) 1990-10-30
PH27020A (en) 1993-02-01
NO904694L (no) 1991-05-02
EP0426021A1 (en) 1991-05-08
JPH03188076A (ja) 1991-08-16

Similar Documents

Publication Publication Date Title
FI905200A0 (fi) Kondenserade imidazolderivat och foerfarande foer deras framstaellning.
FI923577A0 (fi) Anordning och foerfarande foer bestraolning av celler.
FI900160A0 (fi) Fluorsilikonfoereningar och kompositioner foer limslaeppliner.
FI894025A0 (fi) Kyvettmatris och staell foer denna.
FI900545A0 (fi) Spets foer tandspruta och spruthaollare foer densamma.
FI900903A0 (fi) Hoelje foer roekartiklar och foerfarande foer tillverkning daerav.
FI900885A0 (fi) Vissa piroktonsalter och parfymer innehaollande deodorantkompositioner.
FI893797A (fi) Kapacitiv fuktighetsgivarkonstruktion och foerfarande foer framstaellning daerav.
FI891531A0 (fi) Foerfarande foer varmpressning och torkningsanordning.
FI895649A (fi) Forskningsfoerfarande och anordning.
NO913143L (no) Addisjonskrets for hoeyfrekvenssignaler.
FI920223A0 (fi) Foerfarande och anordning foer framstaellning av slaeta och glansiga papper.
FI902552A0 (fi) Anordning foer samtidig instaellning av en stols ryggstoed och saete.
FI896338A0 (fi) Avisningsaemnen omfattande kalcium -magnesium-acetat och chelatbildare.
FI921433A0 (fi) Stabila emulsionspolymerer och foerfaranden foer deras framstaellning.
FI894184A0 (fi) Spektrometriskt foerfarande och spektrometer.
FI892066A0 (fi) Foerfarande och anordning foer minspaning.
FI900857A0 (fi) Antiarrytmiska azol-1-alkanamider och deras framstaellning.
FI890604A0 (fi) Gjutform och foerfarande foer framstaellning daerav.
FI913653A0 (fi) Gjutform och foerfarande foer framstaellning daerav.
FI905092A0 (fi) Vaeggelement och foerfarande foer dess framstaellning.
FI885321A0 (fi) Foerfarande och anordning foer framstaellning av pappersmassabana.
FI894969A0 (fi) Foervaringskaerl och foerslutare.
FI894050A (fi) Mammografifoerfarande och anordning foer anvaendning daervid.
FI896218A0 (fi) Kalibreringsdon och foerfarande foer framstaellning daerav.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.